Published in Br J Cancer on June 06, 2005
Monitoring and Managing Glucose Levels in People With Pancreatic Cancer (PEGASUS) | NCT05132244
Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med (2011) 10.33
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia (2009) 7.06
Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology (2009) 4.72
Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA (2008) 4.48
Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol (2009) 3.67
Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study. Diabetologia (2011) 3.52
Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 3.51
Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology (2007) 3.20
Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat Med (2014) 3.09
New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol (2009) 2.92
Recent progress in pancreatic cancer. CA Cancer J Clin (2013) 2.88
Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis. PLoS One (2012) 2.84
Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology (2008) 2.58
Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol (2007) 2.40
Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium. Ann Oncol (2014) 2.24
Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer (2011) 2.23
Risk of pancreatic cancer in relation to ABO blood group and hepatitis C virus infection in Korea: a case-control study. J Korean Med Sci (2013) 2.23
Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus. J Clin Oncol (2014) 2.21
Metformin use is associated with better survival of diabetic patients with pancreatic cancer. Clin Cancer Res (2012) 2.17
Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol (2009) 1.87
Cohort study of pioglitazone and cancer incidence in patients with diabetes. Diabetes Care (2011) 1.83
Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer. J Natl Cancer Inst (2013) 1.80
Diabetes and pancreatic cancer. Mol Carcinog (2012) 1.71
Dietary fatty acids and pancreatic cancer in the NIH-AARP diet and health study. J Natl Cancer Inst (2009) 1.71
Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts. Br J Cancer (2005) 1.71
Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study. Cancer (2007) 1.70
Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res (2009) 1.67
Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010. World J Gastroenterol (2011) 1.65
Growth hormone, the insulin-like growth factor axis, insulin and cancer risk. Nat Rev Endocrinol (2010) 1.61
Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp Diabetes Res (2012) 1.55
New insights into pancreatic cancer-induced paraneoplastic diabetes. Nat Rev Gastroenterol Hepatol (2013) 1.54
Lifestyle, dietary, and medical history factors associated with pancreatic cancer risk in Ontario, Canada. Cancer Causes Control (2009) 1.53
The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese. Exp Diabetes Res (2012) 1.53
Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus. CMAJ (2008) 1.45
Temporal association of changes in fasting blood glucose and body mass index with diagnosis of pancreatic cancer. Am J Gastroenterol (2009) 1.39
Plasma 25-hydroxyvitamin D and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.37
The complexities of obesity and diabetes with the development and progression of pancreatic cancer. Biochim Biophys Acta (2010) 1.29
Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Cancer Causes Control (2010) 1.29
New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts. Clin Cancer Res (2010) 1.25
Early diagnosis of pancreatic cancer: challenges and new developments. Biomark Med (2012) 1.23
Epidemiology, risk factors, and the promotion of pancreatic cancer: role of the stellate cell. J Gastroenterol Hepatol (2012) 1.23
Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. Carcinogenesis (2012) 1.20
Excess body weight and obesity--the link with gastrointestinal and hepatobiliary cancer. Nat Rev Gastroenterol Hepatol (2011) 1.18
Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology (2013) 1.18
Body mass index and obesity- and diabetes-associated genotypes and risk for pancreatic cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.17
Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes Control (2012) 1.17
Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease. J Cancer Res Clin Oncol (2010) 1.16
Prediagnostic adiponectin concentrations and pancreatic cancer risk in male smokers. Am J Epidemiol (2008) 1.15
Low LDL cholesterol, albuminuria, and statins for the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry. Diabetes Care (2009) 1.13
Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis. Br J Cancer (2007) 1.11
Diabetes and cancer: two diseases with obesity as a common risk factor. Diabetes Obes Metab (2013) 1.11
Fruit and vegetable consumption is inversely associated with having pancreatic cancer. Cancer Causes Control (2011) 1.10
Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Diabetologia (2011) 1.08
Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells. BMC Cancer (2013) 1.07
Alcohol intake and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan). Cancer Causes Control (2010) 1.07
Convergence of obesity and high glycemic diet on compounding diabetes and cardiovascular risks in modernizing China: an emerging public health dilemma. Global Health (2008) 1.06
Intake of fatty acids and antioxidants and pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area. Int J Cancer (2010) 1.05
Genome-wide "pleiotropy scan" identifies HNF1A region as a novel pancreatic cancer susceptibility locus. Cancer Res (2011) 1.05
Metformin inhibits the growth of human pancreatic cancer xenografts. Pancreas (2013) 1.05
Age and cancer risk: a potentially modifiable relationship. Am J Prev Med (2014) 1.04
The role of chronic inflammation in obesity-associated cancers. ISRN Oncol (2013) 1.04
Diabetes and cancer I: risk, survival, and implications for screening. Cancer Causes Control (2012) 1.04
Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region. Ann Oncol (2010) 1.03
Pre-operative factors that can predict neoplastic polypoid lesions of the gallbladder. World J Gastroenterol (2011) 1.03
Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection. World J Gastroenterol (2014) 1.03
Diabetes mellitus and risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study. Br J Cancer (2013) 1.03
Advances in pancreatic cancer research: moving towards early detection. World J Gastroenterol (2014) 1.02
A prospective study of the associations between treated diabetes and cancer outcomes. Diabetes Care (2011) 1.02
Cancer risk in HBV patients with statin and metformin use: a population-based cohort study. Medicine (Baltimore) (2015) 1.02
Lifetime adiposity and risk of pancreatic cancer in the NIH-AARP Diet and Health Study cohort. Am J Clin Nutr (2013) 1.01
Latest insights into the risk of cancer in diabetes. J Diabetes Investig (2013) 1.01
Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts. Br J Cancer (2007) 1.01
Tumor macroenvironment and metabolism. Semin Oncol (2014) 1.01
Increased risk of cancer in patients with type 2 diabetes mellitus: a retrospective cohort study in China. BMC Public Health (2012) 1.00
Physical activity, diet, and pancreatic cancer: a population-based, case-control study in Minnesota. Nutr Cancer (2009) 1.00
Prevalence of diabetes mellitus in pancreatic cancer compared to common cancers. Pancreas (2013) 1.00
Case-control study of aspirin use and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev (2014) 1.00
Additive interaction between the renin-angiotensin system and lipid metabolism for cancer in type 2 diabetes. Diabetes (2009) 0.99
Interpreting adverse signals in diabetes drug development programs. Diabetes Care (2013) 0.99
An overview of genetic polymorphisms and pancreatic cancer risk in molecular epidemiologic studies. J Epidemiol (2010) 0.99
Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resection. HPB (Oxford) (2012) 0.98
Detection bias and overestimation of bladder cancer risk in type 2 diabetes: a matched cohort study. Diabetes Care (2013) 0.98
The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy. Cancer Res Treat (2015) 0.98
Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev (2008) 0.97
Diabetic ketoacidosis in type 2 diabetics: a novel presentation of pancreatic adenocarcinoma. J Gen Intern Med (2010) 0.97
Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancers. Ann Transl Med (2014) 0.97
Coffee, tea, and sugar-sweetened carbonated soft drink intake and pancreatic cancer risk: a pooled analysis of 14 cohort studies. Cancer Epidemiol Biomarkers Prev (2011) 0.96
New-onset diabetes in pancreatic cancer: a study in the primary care setting. Pancreatology (2012) 0.95
Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort. Br J Cancer (2012) 0.95
The bidirectional interation between pancreatic cancer and diabetes. World J Surg Oncol (2012) 0.95
Available carbohydrates, glycemic load, and pancreatic cancer: is there a link? Am J Epidemiol (2010) 0.95
Pre-existing type 2 diabetes mellitus is an independent risk factor for mortality and progression in patients with renal cell carcinoma. Medicine (Baltimore) (2014) 0.94
Glycemic index, carbohydrates, glycemic load, and the risk of pancreatic cancer in a prospective cohort study. Cancer Epidemiol Biomarkers Prev (2009) 0.94
Epidemiology of pancreatic cancer and the role of family history. J Surg Oncol (2012) 0.94
Effect of diabetes mellitus on outcomes of colorectal cancer. J Korean Soc Coloproctol (2010) 0.94
Sweets, sweetened beverages, and risk of pancreatic cancer in a large population-based case-control study. Cancer Causes Control (2009) 0.93
A twenty-first century cancer epidemic caused by obesity: the involvement of insulin, diabetes, and insulin-like growth factors. Int J Endocrinol (2013) 0.93
Risk factors and early signs of pancreatic cancer in diabetes: screening strategy based on diabetes onset age. J Gastroenterol (2012) 0.93
Long-Term Diabetes Mellitus Is Associated with an Increased Risk of Pancreatic Cancer: A Meta-Analysis. PLoS One (2015) 0.93
A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Eur J Cancer (2011) 0.93
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79
Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J (1976) 28.28
Fasting serum glucose level and cancer risk in Korean men and women. JAMA (2005) 6.69
Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol (2004) 5.29
Aspirin use and risk of fatal cancer. Cancer Res (1993) 4.14
Abnormal glucose metabolism and pancreatic cancer mortality. JAMA (2000) 4.01
Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA (1995) 3.83
Diabetes and the risk of pancreatic cancer. N Engl J Med (1994) 3.78
Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst (1997) 3.57
Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology (2001) 3.51
Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol (2002) 2.83
Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer (1999) 2.66
Epidemiology of cancer of the pancreas. J Natl Cancer Inst (1973) 2.37
A multifactorial model for pancreatic cancer in man. Epidemiologic evidence. JAMA (1981) 2.35
A prospective study of pancreatic cancer in the elderly. Int J Cancer (1994) 2.25
Cancer risk in patients with diabetes mellitus. Cancer Causes Control (1991) 2.18
Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults. Cancer Causes Control (1998) 2.04
Cancer mortality among diabetics. J Natl Cancer Inst (1970) 2.03
A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer (2003) 2.02
Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis (1982) 1.99
Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: a case-control study in northern Italy. Pancreas (2003) 1.98
Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control (2000) 1.97
Pancreatic cancer, alcohol, diabetes mellitus and gall-bladder disease. Int J Cancer (1989) 1.88
Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Inst (2003) 1.79
A case-control study of diabetes mellitus and cancer risk. Br J Cancer (1994) 1.76
Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study. Cancer Causes Control (2004) 1.74
Dietary habits and past medical history as related to fatal pancreas cancer risk among Adventists. Cancer (1988) 1.73
The relationship between diabetes and pancreatic cancer. Mol Cancer (2003) 1.72
Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial. Ann Intern Med (2005) 1.71
Diabetes mellitus and cancer risk: a multisite case-control study. J Chronic Dis (1985) 1.63
Risk of pancreatic cancer following diabetes mellitus: a nationwide cohort study in Sweden. J Natl Cancer Inst (1995) 1.62
Diabetes and pancreatic carcinoma. Diabete Metab (1994) 1.59
Risk factors for pancreatic cancer: a case-control study based on direct interviews. Teratog Carcinog Mutagen (2001) 1.59
Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology (2003) 1.59
Tobacco, ethanol, coffee, pancreatitis, diabetes mellitus, and cholelithiasis as risk factors for pancreatic carcinoma. Cancer Causes Control (1993) 1.49
Diet and other risk factors for cancer of the pancreas. Cancer (1985) 1.47
Changing aspirin use in patients with Type 2 diabetes in the UKPDS. Diabet Med (2004) 1.40
A case-control study of diet and cancer of the pancreas. Am J Epidemiol (1991) 1.40
Risk of pancreatic cancer in relation to medical history and the use of tobacco, alcohol and coffee. Int J Cancer (1990) 1.40
Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer. J Natl Cancer Inst (2002) 1.37
Socio-economic and lifestyle factors associated with the risk of prostate cancer. Br J Cancer (2000) 1.33
Aspects of medical history and exocrine carcinoma of the pancreas: a population-based case-control study in The Netherlands. Int J Cancer (1992) 1.31
Risk of pancreatic cancer in relation to alcohol drinking, coffee consumption and medical history: findings from the Japan collaborative cohort study for evaluation of cancer risk. Int J Cancer (2002) 1.27
Early precursors of pancreatic cancer in college men. J Chronic Dis (1983) 1.26
Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor? Am J Surg (1993) 1.25
Coffee and alcohol as determinants of risk of pancreas cancer: a case-control study from Toronto. Int J Cancer (1991) 1.23
Medical history, diet and pancreatic cancer. Oncology (1990) 1.22
Epidemiology of pancreatic cancer in Japan: a nested case-control study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC). Int J Epidemiol (2003) 1.21
Risk factors for pancreatic cancer: an exploratory study. Int J Epidemiol (1993) 1.19
Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men. Am J Epidemiol (1992) 1.17
Pancreatic cancer, blood glucose and beverage consumption. Int J Cancer (1988) 1.15
Risk factors for pancreatic cancer in orientals. J Gastroenterol Hepatol (1996) 0.97
Diabetes, gall stone disease, and pancreatic cancer. Br J Cancer (1986) 0.97
[Diabetes mellitus and pancreatic cancer: a case-control study in greater Montreal, Quebec, Canada]. Rev Epidemiol Sante Publique (1992) 0.93
Pancreatic cancer and diabetes: is there a relationship? A case-controlled study. Aust N Z J Surg (2000) 0.92
Mortality of Japanese diabetics in a seven-year follow-up study. Diabetes Res Clin Pract (1986) 0.86
Cancer arising after pancreas and/or kidney transplantation in a series of 99 diabetic patients. Diabetes Care (1997) 0.86
Imaging beta-amyloid burden in aging and dementia. Neurology (2007) 7.70
Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia (2009) 6.55
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants. Int J Epidemiol (2004) 4.67
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care (2004) 2.77
Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol (2003) 2.57
Accuracy of the estimated prevalence of obesity from self reported height and weight in an adult Scottish population. J Epidemiol Community Health (2000) 2.50
The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care (2003) 2.36
Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev (2008) 2.32
By neglecting deprivation, cardiovascular risk scoring will exacerbate social gradients in disease. Heart (2005) 2.32
Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia (2011) 2.28
Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer (2006) 2.27
Cardiovascular risk prediction tools for populations in Asia. J Epidemiol Community Health (2007) 2.25
First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis. Br J Psychiatry (2008) 2.24
Effects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: a meta-analysis of randomised trials. Lancet (2014) 2.18
Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille). Eur Heart J (2004) 2.18
Smoking, quitting, and the risk of cardiovascular disease among women and men in the Asia-Pacific region. Int J Epidemiol (2005) 2.16
Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. J Hypertens (2007) 2.01
Passive smoking by self report and serum cotinine and the prevalence of respiratory and coronary heart disease in the Scottish heart health study. J Epidemiol Community Health (1995) 1.83
Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation (2004) 1.72
Development of a database of organ doses for paediatric and young adult CT scans in the United Kingdom. Radiat Prot Dosimetry (2012) 1.71
Nutrient intakes of different social-class groups: results from the Scottish Heart Health Study (SHHS). Br J Nutr (1991) 1.67
Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chart. Eur Heart J (2001) 1.66
Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology (Oxford) (2001) 1.63
Helicobacter pylori infection and coronary heart disease in the North Glasgow MONICA population. Eur Heart J (1997) 1.60
Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial. Stroke (2003) 1.60
A one-quarter reduction in the salt content of bread can be made without detection. Eur J Clin Nutr (2003) 1.57
Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review. Heart (2011) 1.52
Experimental Salmonella enteritidis infection in chicks. Vet Rec (1989) 1.50
The ultrastructure of chronic radiation damage in rat skin. Surg Gynecol Obstet (1981) 1.43
Preventing diabetes complications: are we too glucocentric? Int J Clin Pract (2010) 1.42
Cohort profile: the Asia Pacific Cohort Studies Collaboration. Int J Epidemiol (2006) 1.39
Outcome of the Lima periurethral constrictor in children and adolescents: a European perspective. J Urol (2012) 1.38
Variation in coronary risk factors by social status: results from the Scottish Heart Health Study. Br J Gen Pract (1992) 1.29
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27
Systolic blood pressure, diabetes and the risk of cardiovascular diseases in the Asia-Pacific region. J Hypertens (2007) 1.25
APOE genotype, ethnicity, and the risk of cerebral hemorrhage. Neurology (2008) 1.24
Evaluation of the usability of a brief computerized cognitive screening test in older people for epidemiological studies. Neuroepidemiology (2009) 1.20
High prevalence of chronic kidney disease in Thailand. Kidney Int (2007) 1.19
The fraction of ischaemic heart disease and stroke attributable to smoking in the WHO Western Pacific and South-East Asian regions. Tob Control (2006) 1.18
Medical exposure to radiation and thyroid cancer. Clin Oncol (R Coll Radiol) (2011) 1.17
A comparison of the associations between risk factors and cardiovascular disease in Asia and Australasia. Eur J Cardiovasc Prev Rehabil (2005) 1.17
A comparison of lipid variables as predictors of cardiovascular disease in the Asia Pacific region. Ann Epidemiol (2005) 1.17
Oral disease in relation to future risk of dementia and cognitive decline: prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial. Eur Psychiatry (2011) 1.15
Mediterranean diet and all-causes mortality after myocardial infarction: results from the GISSI-Prevenzione trial. Eur J Clin Nutr (2003) 1.14
Coffee and tea consumption and the prevalence of coronary heart disease in men and women: results from the Scottish Heart Health Study. J Epidemiol Community Health (1993) 1.13
Impact of smoking and smoking cessation on lung cancer mortality in the Asia-Pacific region. Am J Epidemiol (2007) 1.13
Association of p53 and WAF1 expression with apoptosis in diffuse alveolar damage. Am J Pathol (1996) 1.11
Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial. Stroke (2003) 1.11
A cohort study of 20,822 young drivers: the DRIVE study methods and population. Inj Prev (2006) 1.10
Contractile fibroblasts in chronic alcoholic cirrhosis. Gastroenterology (1979) 1.10
Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study. Br Heart J (1993) 1.09
Adult height and cancer mortality in Asia: the Asia Pacific Cohort Studies Collaboration. Ann Oncol (2009) 1.08
Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol (1997) 1.08
Evidence that high von Willebrand factor and low ADAMTS-13 levels independently increase the risk of a non-fatal heart attack. J Thromb Haemost (2008) 1.07
The drinking, passive smoking, smoking deception and serum cotinine in the Scottish Heart Health Study. J Clin Epidemiol (1991) 1.07
The hazards and benefits associated with smoking and smoking cessation in Asia: a meta-analysis of prospective studies. Tob Control (2009) 1.07
Legionnaires disease in Reading--possible association with a cooling tower. Community Med (1985) 1.06
Dietary composition and fat to sugar ratios in relation to obesity. Int J Obes Relat Metab Disord (1994) 1.04
The discrimination of dyslipidaemia using anthropometric measures in ethnically diverse populations of the Asia-Pacific Region: the Obesity in Asia Collaboration. Obes Rev (2009) 1.04
Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region. Ann Oncol (2010) 1.03
Dietary antioxidant vitamins and fiber in the etiology of cardiovascular disease and all-causes mortality: results from the Scottish Heart Health Study. Am J Epidemiol (1999) 1.03
The Scottish Heart Health Study. Dietary intake by food frequency questionnaire and odds ratios for coronary heart disease risk. II. The antioxidant vitamins and fibre. Eur J Clin Nutr (1992) 1.01
Nutrient intake by duration of ex-smoking in the Scottish Heart Health Study. Br J Nutr (1993) 1.00
Is a single definition of the metabolic syndrome appropriate?--A comparative study of the USA and Asia. Atherosclerosis (2005) 1.00
The impact of modifiable risk factors on mortality from prostate cancer in populations of the Asia-Pacific region. Asian Pac J Cancer Prev (2007) 0.99
Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus. Diabetologia (2012) 0.96
Intensive glucose control and risk of cancer in patients with type 2 diabetes. Diabetologia (2011) 0.96
Obesity and overweight in relation to liver disease mortality in men: 38 year follow-up of the original Whitehall study. Int J Obes (Lond) (2008) 0.95
Shift work and work injury in the New Zealand Blood Donors' Health Study. Occup Environ Med (2006) 0.95
Weight changes and their predictors amongst 11 140 patients with type 2 diabetes in the ADVANCE trial. Diabetes Obes Metab (2012) 0.94
The ultrastructure and etiology of chronic radiotherapy damage in human skin. Ann Plast Surg (1982) 0.94
Dietary and non-dietary predictors of serum total and HDL-cholesterol in men and women: results from the Scottish Heart Health Study. Int J Epidemiol (1991) 0.92
Unidentified under-nutrition: dietary intake and anthropometric indices in a residential care home population. J Hum Nutr Diet (2006) 0.92
The life cycle of the myofibroblast. Surg Gynecol Obstet (1977) 0.92
Medication management at home: medication risk factor prevalence and inter-relationships. J Clin Pharm Ther (2006) 0.91
Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years. Relationships to hormone replacement therapy. Thromb Haemost (2000) 0.90